Search - tctmd.com

Displaying 121 - 140 of 214

Sort: Relevancy | Date

News Daily News

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Yael L. Maxwell

August 07, 2014

News Daily News

El Intento Regional de Mejora de la Calidad Reduce la LRA Inducida por Contraste Post-PCI

Yael L. Maxwell

August 07, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Daily News

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Yael L. Maxwell

April 15, 2014

News Daily News

Cardiac Cath via Radial Access Safe, Effective for Liver Transplant Patients

Jason Kahn

March 14, 2014

News Daily News

Registry Suggests Link Between PCI Access Route, Kidney Damage

Caitlin E. Cox

March 05, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Caitlin E. Cox

February 12, 2014

News Daily News

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Caitlin E. Cox

February 12, 2014

Presentation TCT 2013

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Somjot Brar

October 30, 2013

Presentation TCT 2013

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

Presenter: Carlo Briguori

October 30, 2013

News Conference News TCT 2013

BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography

October 29, 2013

Presentation TCT 2013

BOSS: A Prospective, Randomized Trial of Bicarbonate vs. Saline for Prevention of Contrast Nephropathy

Presenter: Richard Solomon

October 28, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

News Daily News

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Yael L. Maxwell

August 12, 2013

News Daily News

Morbid Obesity: An Increasing Risk Factor in PCI Patients

L.A. McKeown

June 20, 2013

News Daily News

Pre-oxygenation Reduces Contrast Nephropathy in Elective PCI Patients

Jason Kahn

May 17, 2013

Advertisement

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

El Intento Regional de Mejora de la Calidad Reduce la LRA Inducida por Contraste Post-PCI

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Cardiac Cath via Radial Access Safe, Effective for Liver Transplant Patients

Registry Suggests Link Between PCI Access Route, Kidney Damage

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography

BOSS: A Prospective, Randomized Trial of Bicarbonate vs. Saline for Prevention of Contrast Nephropathy

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Study Looks at Differences in PCI Outcomes at Teaching vs. Non-Teaching Hospitals

Morbid Obesity: An Increasing Risk Factor in PCI Patients

Pre-oxygenation Reduces Contrast Nephropathy in Elective PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content